Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Alzheimer Disease 2Stress Disorders, Post-Traumatic 1Sleep Initiation and Maintenance Disorders 1Sleep Disorders, Circadian Rhythm 1Sleep Deprivation 1REM Sleep Behavior Disorder 1Psychological Well-Being 1Pain 1Otolaryngeal Cancer 1Neoplasm Metastasis 1Lymphoma, Follicular 1Idiopathic Hypersomnia 1Depression 1Dementia 1Combat Disorders 1Cognitive Dysfunction 1Chronobiology Disorders 1Cancer Pain 1Breast Neoplasms 1Anxiety Disorders 1Agnosia 1

Interventions

XENP 1595 2mazdutide 1enzalutamide 1amlodipine, atorvastatin drug combination 1UE2343 1Tomography, X-Ray Computed 1Tomography, Emission-Computed 1Tablets 1Standard of Care 1Referral and Consultation 1Prednisone 1Positron-Emission Tomography 1Methods 1Magnetic Resonance Imaging 1Lysine Acetyltransferase 5 1Hormones 1Gonadotropin-Releasing Hormone 1Exercise 1Ethanol 1Electroencephalography 1Dignity Therapy 1Decision Support Techniques 1Atorvastatin 1Activities of Daily Living 1Accidental Falls 1Abiraterone Acetate 17-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Dementia × Electroencephalography × Clear all
NCT04942184 2022-11-01

STRATEGIES to Improve Memory in Alzheimer's Disease

Boston University

Phase NA Withdrawn
Lymphoid

Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡